Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses.

Chen, Yanjia; Zhao, Xiaoyu; Zhou, Hao; Zhu, Huanzhang; Jiang, Shibo; Wang, Pengfei

Chen, Yanjia; Zhao, Xiaoyu; Zhou, Hao; Zhu, Huanzhang; Jiang, Shibo; Wang, Pengfei.

Afiliación

Chen Y; State Key Laboratory of Genetic Engineering, Shanghai Institute of Infectious Disease and Biosecurity, School of Life Sciences, Fudan University, Shanghai, China.
Zhao X; State Key Laboratory of Genetic Engineering, Shanghai Institute of Infectious Disease and Biosecurity, School of Life Sciences, Fudan University, Shanghai, China.
Zhou H; Department of Microbiology, Grossman School of Medicine, New York University, New York, NY, USA.
Zhu H; College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jiang S; State Key Laboratory of Genetic Engineering, Shanghai Institute of Infectious Disease and Biosecurity, School of Life Sciences, Fudan University, Shanghai, China.
Wang P; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai, China. shibojiang@fudan.edu.cn.

Nat Rev Immunol ; 23(3): 189-199, 2023 03.

Article en En | MEDLINE | ID: mdl-36168054

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; Anticuerpos ampliamente neutralizantes; Pandemias; Anticuerpos Neutralizantes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Nat Rev Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google